Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study

201686 citationsJournal Articlehybrid Open Access

Authors

http://www.clinicaltrials.gov . Unique identifier: NCT01955720.

Good health and well-being

Published in: Clinical Pharmacokinetics

Volume 56, Issue 1, pp. 41-54

Field-Weighted Citation Impact: 12.33